These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 20977322

  • 21. Clinical review of a long-acting, injectable formulation of risperidone.
    Knox ED, Stimmel GL.
    Clin Ther; 2004 Dec; 26(12):1994-2002. PubMed ID: 15823763
    [Abstract] [Full Text] [Related]

  • 22. Effectiveness of risperidone long-acting injection in first-episode schizophrenia: in naturalistic setting.
    Kim B, Lee SH, Choi TK, Suh S, Kim YW, Lee E, Yook KH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul 01; 32(5):1231-5. PubMed ID: 18442879
    [Abstract] [Full Text] [Related]

  • 23. Prospective, open study of long-acting injected risperidone versus oral antipsychotics in 88 chronically psychotic patients.
    Girardi P, Serafini G, Pompili M, Innamorati M, Tatarelli R, Baldessarini RJ.
    Pharmacopsychiatry; 2010 Mar 01; 43(2):66-72. PubMed ID: 20099224
    [Abstract] [Full Text] [Related]

  • 24. Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder.
    Fagiolini A, Casamassima F, Mostacciuolo W, Forgione R, Goracci A, Goldstein BI.
    Expert Opin Pharmacother; 2010 Jul 01; 11(10):1727-40. PubMed ID: 20486830
    [Abstract] [Full Text] [Related]

  • 25. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
    Rossi A, Bagalà A, Del Curatolo V, Scapati F, Bernareggi MM, Giustra MG, Risperidone Long-Acting Trial Investigators (R-LAI).
    Hum Psychopharmacol; 2009 Oct 01; 24(7):574-83. PubMed ID: 19790173
    [Abstract] [Full Text] [Related]

  • 26. [Treatment of bipolar mania with risperidone].
    Schreiner A.
    Psychiatr Prax; 2006 Mar 01; 33 Suppl 1():S12-7. PubMed ID: 16511726
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP, Eerdekens E, Berry SA, Eerdekens M.
    J Clin Psychiatry; 2004 Aug 01; 65(8):1084-9. PubMed ID: 15323593
    [Abstract] [Full Text] [Related]

  • 29. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
    Vehof J, Postma MJ, Bruggeman R, De Jong-Van Den Berg LT, Van Den Berg PB, Stolk RP, Burger H.
    J Clin Psychopharmacol; 2008 Dec 01; 28(6):625-30. PubMed ID: 19011430
    [Abstract] [Full Text] [Related]

  • 30. The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series.
    Se Hyun Kim, Dong Chung Jung, Yong Min Ahn, Yong Sik Kim.
    J Psychopharmacol; 2010 Jul 01; 24(7):981-6. PubMed ID: 19942641
    [Abstract] [Full Text] [Related]

  • 31. Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: reasons for switching and safety.
    Hawley C, Turner M, Latif MA, Curtis V, Saleem PT, Wilton K.
    Hum Psychopharmacol; 2010 Jan 01; 25(1):37-46. PubMed ID: 20041474
    [Abstract] [Full Text] [Related]

  • 32. Risperidone for bipolar disorders.
    Sajatovic M, Madhusoodanan S, Fuller MA, Aulakh L, Keaton DB.
    Expert Rev Neurother; 2005 Mar 01; 5(2):177-87. PubMed ID: 15853488
    [Abstract] [Full Text] [Related]

  • 33. Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients.
    Kissling W, Glue P, Medori R, Simpson S.
    Hum Psychopharmacol; 2007 Dec 01; 22(8):505-13. PubMed ID: 17902187
    [Abstract] [Full Text] [Related]

  • 34. Risperidone in the treatment of affective illness and obsessive-compulsive disorder.
    Jacobsen FM.
    J Clin Psychiatry; 1995 Sep 01; 56(9):423-9. PubMed ID: 7545159
    [Abstract] [Full Text] [Related]

  • 35. Maintenance treatment with long-acting injectable risperidone in first-episode schizophrenia: a randomized effectiveness study.
    Weiden PJ, Schooler NR, Weedon JC, Elmouchtari A, Sunakawa-McMillan A.
    J Clin Psychiatry; 2012 Sep 01; 73(9):1224-33. PubMed ID: 22938760
    [Abstract] [Full Text] [Related]

  • 36. Clinical experience with the long-acting injectable formulation of the atypical antipsychotic, risperidone.
    Martin SD, Libretto SE, Pratt DJ, Brewin JS, Huq ZU, Saleh BT.
    Curr Med Res Opin; 2003 Sep 01; 19(4):298-305. PubMed ID: 12841922
    [Abstract] [Full Text] [Related]

  • 37. [The first long-acting atypical antipsychotic: new milestone in the treatment of schizophrenia].
    Faludi G.
    Neuropsychopharmacol Hung; 2005 Mar 01; 7(1):22-7. PubMed ID: 16167464
    [Abstract] [Full Text] [Related]

  • 38. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
    Raignoux C, Dusouchet T, Bret P, Queuille E, Biscay ML, Caron J, Bret MC.
    Encephale; 2007 Dec 01; 33(6):973-81. PubMed ID: 18789790
    [Abstract] [Full Text] [Related]

  • 39. Antipsychotics in bipolar disorder.
    Gelenberg AJ, Hopkins HS.
    J Clin Psychiatry; 1996 Dec 01; 57 Suppl 9():49-52. PubMed ID: 8823350
    [Abstract] [Full Text] [Related]

  • 40. Does oral antipsychotic pre-treatment influence outcome of a switch to long-acting injectable risperidone in patients with schizophrenia?
    Schmauss M, Diekamp B, Gerwe M, Schreiner A, Ibach B.
    Pharmacopsychiatry; 2010 Mar 01; 43(2):73-80. PubMed ID: 20131207
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.